| Product Code: ETC4471829 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
Blood screening plays a fundamental role in ensuring the safety of blood transfusions and protecting public health. The Indonesian blood screening market encompasses various tests, including those for infectious diseases like HIV, hepatitis, and syphilis, ensuring the safety of the blood supply.
The Indonesia Blood Screening Market is being primarily driven by the rising demand for safe and reliable blood transfusions. Blood screening is crucial in ensuring the safety of blood supply by identifying potential infectious agents, such as HIV, hepatitis, and other bloodborne pathogens. The government`s increasing focus on improving healthcare infrastructure and blood safety standards has further propelled the market. Additionally, the growing number of blood donation campaigns and rising awareness about the importance of regular blood screening among the general population contribute to the market`s expansion.
The Indonesia blood screening market is a critical component of the healthcare sector, ensuring the safety of blood transfusions and the early detection of bloodborne diseases. However, challenges persist in terms of regulatory compliance, infrastructure, and resources. One significant challenge is maintaining a robust supply chain and quality control, which can be hampered by logistical difficulties in the vast archipelago. Additionally, the need for advanced equipment and skilled personnel poses a challenge in many remote regions of the country.
Blood screening faced challenges during the pandemic, with a temporary reduction in non-essential screenings. Blood donation drives were also impacted, affecting the availability of blood products. As the healthcare system adapted to the pandemic, the market experienced a recovery in demand for blood screening and a renewed focus on safety and screening protocols.
Prominent players in the Indonesia Blood Screening market include Ortho Clinical Diagnostics, Grifols, and F. Hoffmann-La Roche. They offer comprehensive blood screening solutions for ensuring safe blood transfusions and reducing the risk of infectious diseases.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Blood Screening Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Blood Screening Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Blood Screening Market - Industry Life Cycle |
3.4 Indonesia Blood Screening Market - Porter's Five Forces |
3.5 Indonesia Blood Screening Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Indonesia Blood Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Indonesia Blood Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Indonesia Blood Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of blood screening in Indonesia |
4.2.2 Rise in government initiatives to promote blood screening programs |
4.2.3 Growing prevalence of infectious diseases in the region |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals for blood screening procedures |
4.3.2 Insufficient infrastructure and resources for blood screening in remote areas of Indonesia |
4.3.3 High cost associated with advanced blood screening technologies |
5 Indonesia Blood Screening Market Trends |
6 Indonesia Blood Screening Market, By Types |
6.1 Indonesia Blood Screening Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Blood Screening Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 Indonesia Blood Screening Market Revenues & Volume, By Instruments, 2021-2031F |
6.1.4 Indonesia Blood Screening Market Revenues & Volume, By Reagents & Kits, 2021-2031F |
6.2 Indonesia Blood Screening Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Blood Screening Market Revenues & Volume, By Molecular Tests, 2021-2031F |
6.2.3 Indonesia Blood Screening Market Revenues & Volume, By Serology Tests, 2021-2031F |
6.3 Indonesia Blood Screening Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Blood Screening Market Revenues & Volume, By Independent Clinical Laboratories, 2021-2031F |
6.3.3 Indonesia Blood Screening Market Revenues & Volume, By Hospital-based Laboratories, 2021-2031F |
6.3.4 Indonesia Blood Screening Market Revenues & Volume, By Others, 2021-2031F |
7 Indonesia Blood Screening Market Import-Export Trade Statistics |
7.1 Indonesia Blood Screening Market Export to Major Countries |
7.2 Indonesia Blood Screening Market Imports from Major Countries |
8 Indonesia Blood Screening Market Key Performance Indicators |
8.1 Percentage increase in the number of blood screening facilities in Indonesia |
8.2 Average waiting time for individuals to receive blood screening results |
8.3 Number of individuals participating in voluntary blood screening programs |
8.4 Rate of adoption of new blood screening technologies |
8.5 Percentage of successful blood screening tests conducted |
9 Indonesia Blood Screening Market - Opportunity Assessment |
9.1 Indonesia Blood Screening Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Indonesia Blood Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Indonesia Blood Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Indonesia Blood Screening Market - Competitive Landscape |
10.1 Indonesia Blood Screening Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Blood Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |